Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Other Accumulated Expenses (2019 - 2025)

Historic Other Accumulated Expenses for Outset Medical (OM) over the last 7 years, with Q4 2025 value amounting to $4.1 million.

  • Outset Medical's Other Accumulated Expenses rose 3171.52% to $4.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $4.1 million, marking a year-over-year increase of 3171.52%. This contributed to the annual value of $4.1 million for FY2025, which is 3171.52% up from last year.
  • Outset Medical's Other Accumulated Expenses amounted to $4.1 million in Q4 2025, which was up 3171.52% from $3.6 million recorded in Q3 2025.
  • Over the past 5 years, Outset Medical's Other Accumulated Expenses peaked at $7.1 million during Q4 2022, and registered a low of $2.3 million during Q1 2021.
  • For the 5-year period, Outset Medical's Other Accumulated Expenses averaged around $4.5 million, with its median value being $4.4 million (2023).
  • As far as peak fluctuations go, Outset Medical's Other Accumulated Expenses soared by 18713.37% in 2021, and later plummeted by 4772.29% in 2025.
  • Over the past 5 years, Outset Medical's Other Accumulated Expenses (Quarter) stood at $4.0 million in 2021, then surged by 76.97% to $7.1 million in 2022, then fell by 18.96% to $5.8 million in 2023, then crashed by 46.36% to $3.1 million in 2024, then surged by 31.72% to $4.1 million in 2025.
  • Its Other Accumulated Expenses stands at $4.1 million for Q4 2025, versus $3.6 million for Q3 2025 and $3.2 million for Q2 2025.